Professor, Clinical Education-Chattanooga, University of Tennessee Health Science Center College of Medicine
Nephrology
Dr. James A. Tumlin, MD
|
|
Give Review
Doctor James A. Tumlin, MD is an expert in the field of Nephrology. He studied medicine at University of South Florida College of Medicine. University of South Florida College of Medicine is ranked 79/85 in Research/PrimaryCare. He has 1 awards "CMS Meaningful Use Stage 1 Certification". James Tumlin is also published. He has 62 publications published. The lastest publication: "Lupus nephritis: novel immunosuppressive modalities and future directions.'
Publications
- Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity.
- Association of Elevated Urinary Concentration of Renin-Angiotensin System Components and Severe AKI.
- The effect of the selective cytopheretic device on Acute kidney injury outcomes in the intensive care unit: a multicenter pilot study.
- Evaluation of 32 urine biomarkers to predict the progression of Acute kidney injury after cardiac surgery.
- Urinary Angiotensinogen and Risk of Severe AKI.
- Soluble urokinase receptor and focal segmental glomerulosclerosis.
- Immediate complications of intravenous contrast for computed tomography imaging in the outpatient setting are rare.
- Incidence of contrast-induced Nephropathy after contrast-enhanced computed tomography in the outpatient setting.
- Impaired blood flow in Acute kidney injury: pathophysiology and potential efficacy of intrarenal vasodilator therapy.
- Prostaglandin-based renal protection against contrast-induced Acute kidney injury.
- T-cell receptor-stimulated calcineurin activity is inhibited in isolated T cells from transplant patients.
- Fenoldopam reduces the need for Renal replacement therapy and in-hospital death in cardiovascular surgery: a meta-analysis.
- Lupus Nephritis: histology, diagnosis, and treatment.
- Idiopathic IgA Nephropathy: pathogenesis, histopathology, and therapeutic options.
- Loss of the alpha-isoform of calcineurin is sufficient to induce nephrotoxicity and altered expression of transforming growth factor-beta.
- Beneficial impact of fenoldopam in critically ill patients with or at risk for Acute renal failure: a meta-analysis of randomized clinical trials.
- A prospective, open-label trial of sirolimus in the treatment of focal segmental glomerulosclerosis.
- Fenoldopam mesylate in early Acute tubular necrosis: a randomized, double-blind, placebo-controlled clinical trial.
- Clinical presentation, natural history, and treatment of crescentic proliferative IgA Nephropathy.
- Calcineurin phosphatase activity: activation by glucocorticoids and role of intracellular Calcium.
- Angiotensin II stimulates calcineurin activity in proximal tubule epithelia through AT-1 receptor-mediated tyrosine phosphorylation of the PLC-gamma1 isoform.
- Efficacy and safety of renal tubule cell therapy for Acute renal failure.
- Improvement in health-related quality of life in systemic lupus erythematosus patients enrolled in a randomized clinical trial comparing LJP 394 treatment With placebo.
- A phase III, randomized, double-blind, placebo-controlled study of tenecteplase for improvement of hemodialysis catheter function: TROPICS 3.
- Systemic lupus international collaborating clinics Renal activity/response exercise: development of a Renal activity score and Renal response index.
- Systemic lupus international collaborating clinics Renal activity/response exercise: comparison of agreement in rating Renal response.
- A longitudinal study of uremic pruritus in hemodialysis patients.
- Epidemiology and prognostic implications of contrast-induced Nephropathy.
- Pathophysiology of contrast-induced Nephropathy.
- Risk prediction of contrast-induced Nephropathy.
- Contrast-induced Nephropathy: is the picture any clearer?
- Primary prevention of Acute renal failure in the critically ill.
- Risk factors for Acute renal failure: inherent and modifiable risks.
- Strategies to reduce the risk of contrast-induced Nephropathy.
- Economic burden of contrast-induced Nephropathy: implications for prevention strategies.
- High-risk situations and procedures.
- Contrast medium use.
- Cardiorenal Syndrome Type 4: Insights on Clinical Presentation and Pathophysiology from the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQI).
- Baseline Renal function screening.
- Advanced diabetic nephropathy With nephrotic range proteinuria: a pilot study of the long-term efficacy of subcutaneous ACTH gel on proteinuria, progression of CKD, an...
- Abetimus sodium for Renal flare in systemic lupus erythematosus: results of a randomized, controlled phase III trial.
- Treatment of nephrotic syndrome With adrenocorticotropic hormone (ACTH) gel.
- Contrast-Induced Nephropathy (CIN) Consensus Working Panel: executive summary.
- Fenoldopam mesylate for the prevention of contrast-induced Nephropathy: a randomized controlled trial.
- LJP 394 for the prevention of renal flare in patients With systemic lupus erythematosus: results from a randomized, double-blind, placebo-controlled study.
- Crescentic, proliferative IgA nephropathy: clinical and histological Response to methylprednisolone and intravenous cyclophosphamide.
- Design and rationale of CONTRAST--a prospective, randomized, placebo-controlled trial of fenoldopam mesylate for the prevention of radiocontrast Nephropathy.
- LJP 394 (abetimus sodium, Riquent) in the management of systemic lupus erythematosus.
- Hemolytic-uremic Syndrome following "crack" cocaine inhalation.
- Expression of calcineurin activity and alpha-subunit isoforms in specific segments of the rat nephron.
- Evidence that the inhibition of Na+/K(+)-ATPase activity by FK506 involves calcineurin.
- Sodium-dependent net urea transport in rat initial inner medullary collecting ducts.
- Expression of Na-K-ATPase alpha- and beta-subunit mRNA and protein isoforms in the rat nephron.
- Nephron segment-specific inhibition of Na+/K(+)-ATPase activity by cyclosporin A.
- Case report: delayed hypercalcemia after rhabdomyolysis-induced Acute renal failure.
- Aldosterone and dexamethasone stimulate calcineurin activity through a transcription-independent mechanism involving steroid receptor-associated heat shock proteins.
- Expression and function of calcineurin in the mammalian nephron: physiological roles, receptor signaling, and ion transport.
- Lupus Nephritis: novel immunosuppressive modalities and future directions.
- Heat shock proteins 70 and 90 increase calcineurin activity in vitro through calmodulin-dependent and independent mechanisms.
- Fenoldopam, a dopamine agonist, for Hypertensive emergency: a multicenter randomized trial. Fenoldopam Study Group.
- Fenoldopam mesylate blocks reductions in Renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy.
Schools
University Of South Florida College Of Medicine
Emory University Hospital
Emory University School Of Med
Procedures Preformed
- Arteriovenostomy for Renal Dialysis
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acidosis
- Acute GlomeruloNephritis
- Acute Kidney Failure
- Alkalosis
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Emory University -
University of South Florida College of Medicine
Hospital
-
University of Tennessee Medical Center
Drug Facts
| NPI NUMBER | 1467418053 | |
| NPPES Provider LastName | TUMLIN | |
| NPPES Provider FirstName | JAMES | |
| NPPES Provider ZIPCode | 374042739 | |
| NPPES Provider State | TN | |
| Specialty Description | Neurology | |
| Total Claim Count | 1068.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 25.0 | |
| Percent Opioid Claims | 2.34 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1467418053 |
| Last Name Of The Provider | TUMLIN |
| First Name Of The Provider | JAMES |
| View All |
Similar Doctors
|
|
Dr. Lindsay C. Crawford, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mandeep S. Grewal, MD |
|
|
Dr. Donald B. Franklin Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nathan E. Chamberlain, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph T. Watlington, MD |
|
|
Dr. Stuart G. Ginther, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adel N. Shenouda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Claude M. Galphin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rohit K. Gupta, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher V. Poole, MD
This Doctor is OpenDoctor Recommended.
|